Social media has long been a valuable source of personally identifiable information (PII) for cybercriminals, but the rise of ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
Texas A&M AgriLife faculty, staff and graduate students earn Vice Chancellor’s Awards in Excellence honors at Texas A&M ...
Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...
Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA– Positioned U.S.-based biomanufacturing ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...
Cybersecurity has evolved from a technical discipline to a board-level business imperative. It determines enterprise ...
Google Cloud’s lead engineer for databases discusses the challenges of integrating databases and LLMs, the tools needed to ...
New Platform Empowers Automakers to Shift Software Engineering Focus from Infrastructure to Innovation LAS VEGAS, NEVADA / ACCESS Newswire / January 6, 2026 / QNX, a division of BlackBerry Limited (NY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback